Entero Therapeutics, Inc.(ENTO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENTO Entero Therapeutics, Inc.

交易中 12-20 12:34:16 EST

0.6100

-0.0084

-1.36%

最高0.6216	最低0.5735	成交量4.07万
今开0.5998	昨收0.6184	日振幅7.78%
总市值290.00万	流通市值285.74万	总股本475.40万
成交额2.43万	换手率0.87%	流通股本468.43万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENTO","market":"US","secType":"STK","nameCN":"Entero Therapeutics, Inc.","latestPrice":0.61,"timestamp":1734715640132,"preClose":0.6184,"halted":0,"volume":40733,"delay":0,"floatShares":4684300,"shares":4754030,"eps":-4.144875,"marketStatus":"交易中","marketStatusCode":2,"change":-0.0084,"latestTime":"12-20 12:34:16 EST","open":0.5998,"high":0.6216,"low":0.5735,"amount":24253.291739599998,"amplitude":0.077781,"askPrice":0.67,"askSize":281,"bidPrice":0.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.144875,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734728400000},"adr":0,"listingDate":1476158400000,"adjPreClose":0.6184,"preHourTrading":{"tag":"盘前","latestPrice":0.5603,"preClose":0.6184,"latestTime":"08:18 EST","volume":1,"amount":0.5603,"timestamp":1734700711460},"postHourTrading":{"tag":"盘后","latestPrice":0.5707,"preClose":0.6184,"latestTime":"19:31 EST","volume":23130,"amount":13206.168,"timestamp":1734654701389},"volumeRatio":0.91263},"requestUrl":"/m/hq/s/ENTO","defaultTab":"news","newsList":[{"id":"2493426217","title":"Entero Therapeutics Inc.盘中异动 临近午盘大幅下跌7.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493426217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493426217?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:35","pubTimestamp":1734712520,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时35分，Entero Therapeutics Inc.股票出现波动，股价急速下挫7.26%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2502.63%、373.59%、93.95%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.，振幅分别为173.15%、155.76%、105.11%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003520ab8799a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003520ab8799a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139"],"gpt_icon":0},{"id":"2492171659","title":"Entero Therapeutics Inc.盘中异动 大幅拉升12.05%报0.628美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492171659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492171659?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:41","pubTimestamp":1734619290,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时41分，Entero Therapeutics Inc.股票出现异动，股价急速上涨12.05%。截至发稿，该股报0.628美元/股，成交量2186股，换手率0.05%，振幅0.00%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为2.35%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922413095ea7aec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922413095ea7aec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ENTO"],"gpt_icon":0},{"id":"2492182261","title":"Entero Therapeutics Inc.盘中异动 早盘大幅上涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492182261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492182261?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:47","pubTimestamp":1734533276,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时47分，Entero Therapeutics Inc.股票出现波动，股价快速上涨5.94%。截至发稿，该股报0.580美元/股，成交量1222股，换手率0.03%，振幅0.00%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224756ab820e5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218224756ab820e5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ENTO"],"gpt_icon":0},{"id":"2491692477","title":"Entero Therapeutics Inc.盘中异动 股价大跌7.50%报0.540美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692477?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359492,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分，Entero Therapeutics Inc.股票出现异动，股价急速跳水7.50%。截至发稿，该股报0.540美元/股，成交量2596股，换手率0.05%，振幅0.00%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223132a1f3429a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223132a1f3429a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139"],"gpt_icon":0},{"id":"2491379583","title":"Entero Therapeutics Inc.盘中异动 股价大跌7.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491379583","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491379583?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:33","pubTimestamp":1734100430,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时33分，Entero Therapeutics Inc.股票出现波动，股价大幅下跌7.36%。截至发稿，该股报0.581美元/股，成交量2804股，换手率0.06%，振幅2.65%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223350a1ec33d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223350a1ec33d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ENTO"],"gpt_icon":0},{"id":"2490019534","title":"Entero Therapeutics Inc.盘中异动 快速跳水6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490019534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490019534?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:31","pubTimestamp":1733841112,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时31分，Entero Therapeutics Inc.股票出现异动，股价快速下跌6.25%。截至发稿，该股报0.750美元/股，成交量8.6779万股，换手率1.83%，振幅5.00%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223153ab6cf59c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223153ab6cf59c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTO","LENZ"],"gpt_icon":0},{"id":"2490775840","title":"Entero Therapeutics Inc.盘中异动 大幅上涨9.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490775840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490775840?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:31","pubTimestamp":1733754704,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时31分，Entero Therapeutics Inc.股票出现波动，股价急速上涨9.18%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Sonnet Biotherapeutics Holdings, Inc.、Metagenomi, Inc.涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为2046.42%、23.49%、18.60%，振幅较大的相关个股有Relmada Therapeutics, Inc.、Sab Biotherapeutics, Inc.、Scpharmaceuticals Inc.，振幅分别为109.29%、103.26%、102.32%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223144a1e0a7f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223144a1e0a7f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139"],"gpt_icon":0},{"id":"2489592239","title":"Entero Therapeutics Inc.盘中异动 股价大涨8.09%报0.720美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489592239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489592239?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:39","pubTimestamp":1733495989,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时39分，Entero Therapeutics Inc.股票出现波动，股价急速拉升8.09%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Exicure, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为28.32%、26.18%、14.14%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Renovaro Inc.、Ensysce Biosciences, Inc.，振幅分别为15.96%、13.21%、13.20%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223949ab62d98d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223949ab62d98d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ENTO","BK4139"],"gpt_icon":0},{"id":"2488518947","title":"Entero Therapeutics Inc.盘中异动 大幅上涨8.70%报0.500美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488518947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488518947?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:48","pubTimestamp":1733240881,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时48分，Entero Therapeutics Inc.股票出现波动，股价快速拉升8.70%。截至发稿，该股报0.500美元/股，成交量1273股，换手率0.03%，振幅8.67%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203234801a269bca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203234801a269bca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTO","LENZ"],"gpt_icon":0},{"id":"2486878496","title":"Entero Therapeutics Inc.股价重挫11.35% 市值跌22.26万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486878496","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486878496?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:56","pubTimestamp":1732719362,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时56分，Entero Therapeutics Inc.股票出现异动，股价急速跳水11.35%。截至发稿，该股报0.412美元/股，成交量9429股，换手率0.20%，振幅10.98%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127225602a259fc85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127225602a259fc85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ENTO","BK4139"],"gpt_icon":0},{"id":"2486053036","title":"Entero Therapeutics Inc.盘中异动 大幅上涨7.57%报0.488美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486053036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486053036?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:42","pubTimestamp":1732549377,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时42分，Entero Therapeutics Inc.股票出现异动，股价大幅上涨7.57%。截至发稿，该股报0.488美元/股，成交量6246股，换手率0.13%，振幅3.68%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.99%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125234257971a86aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125234257971a86aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTO","LENZ"],"gpt_icon":0},{"id":"2485501261","title":"Entero Therapeutics Inc.盘中异动 早盘急速下挫6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485501261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485501261?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:42","pubTimestamp":1732286532,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时42分，Entero Therapeutics Inc.股票出现异动，股价急速下跌6.02%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为864.54%、75.49%、68.76%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为44.82%、33.24%、30.69%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222421298e442a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222421298e442a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ENTO","BK4139"],"gpt_icon":0},{"id":"2484592649","title":"Entero Therapeutics Inc.盘中异动 早盘大幅跳水6.38%报0.412美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484592649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484592649?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:09","pubTimestamp":1732028977,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时09分，Entero Therapeutics Inc.股票出现异动，股价大幅下跌6.38%。截至发稿，该股报0.412美元/股，成交量2.5664万股，换手率0.54%，振幅2.27%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.29%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119230937971a774f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119230937971a774f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","BK4139","LENZ"],"gpt_icon":0},{"id":"2484367667","title":"Entero Therapeutics Inc.盘中异动 股价大跌6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484367667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484367667?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:32","pubTimestamp":1731940379,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时32分，Entero Therapeutics Inc.股票出现异动，股价急速下跌6.29%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为517.22%、208.47%、189.28%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.，振幅分别为50.92%、34.31%、27.23%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822325998e433cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822325998e433cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTO","LENZ"],"gpt_icon":0},{"id":"2483807869","title":"Entero Therapeutics Inc.盘中异动 股价大跌6.98%报0.586美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483807869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483807869?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:33","pubTimestamp":1731594780,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时33分，Entero Therapeutics Inc.股票出现波动，股价急速下跌6.98%。截至发稿，该股报0.586美元/股，成交量3.8391万股，换手率0.81%，振幅2.38%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223300a237d286&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223300a237d286&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","BK4139","LENZ"],"gpt_icon":0},{"id":"2483946498","title":"Entero Therapeutics Inc  预计每股亏损 41 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483946498","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483946498?lang=zh_cn&edition=full","pubTime":"2024-11-14 11:53","pubTimestamp":1731556405,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc  预计每股亏损 41 美分 - 财报前瞻11 月 13 日，Entero Therapeutics Inc ENTO.OQ ENTO.O 将公布截至 2024 年 12 月 31 日的财报，预计季度收入将保持不变。LSEG 的分析师平均预计 Entero Therapeutics Inc 每股亏损 41 美分。华尔街对 Entero Therapeutics Inc 的 12 个月目标价中位数为 36.00 美元，高于上一次 0.63 美元的收盘价。11月14日 - 本摘要于北京时间 11 月 14 日 03:52 机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML0AJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO"],"gpt_icon":0},{"id":"2482452115","title":"Entero Therapeutics Inc  预计每股亏损 32 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482452115","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482452115?lang=zh_cn&edition=full","pubTime":"2024-11-09 06:19","pubTimestamp":1731104348,"startTime":"0","endTime":"0","summary":"Entero Therapeutics Inc  预计每股亏损 32 美分 - 财报前瞻Entero Therapeutics Inc ENTO.OQ ENTO.O 预计在 11 月 11 日公布截至 2024 年 9 月 30 日的财报(估计) 时，季度收入将没有变化。LSEG 的分析师平均预计 Entero Therapeutics Inc 每股亏损 32 美分。华尔街对 Entero Therapeutics Inc 的 12 个月目标价中位数为 36.00 美元，高于其 0.66 美元的最新收盘价。11月8日 - 本摘要于北京时间 11 月 8 日 22:19 机器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF2UN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO"],"gpt_icon":0},{"id":"2481410190","title":"Entero Therapeutics Inc.盘中异动 股价大涨8.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481410190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481410190?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:34","pubTimestamp":1731076469,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时34分，Entero Therapeutics Inc.股票出现异动，股价大幅上涨8.52%。截至发稿，该股报0.716美元/股，成交量1568股，换手率0.03%，振幅8.52%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822342995bdef93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822342995bdef93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ENTO"],"gpt_icon":0},{"id":"2481983294","title":"Entero Therapeutics Inc.盘中异动 早盘大幅跳水8.84%报0.650美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481983294?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903557,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Entero Therapeutics Inc.股票出现波动，股价急速下跌8.84%。截至发稿，该股报0.650美元/股，成交量3771股，换手率0.08%，振幅0.00%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223238971a4bfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223238971a4bfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ENTO"],"gpt_icon":0},{"id":"2481538743","title":"Entero Therapeutics Inc.盘中异动 早盘股价大跌7.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481538743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481538743?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:57","pubTimestamp":1730735842,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时57分，Entero Therapeutics Inc.股票出现异动，股价急速下挫7.63%。截至发稿，该股报0.636美元/股，成交量5.0797万股，换手率1.07%，振幅8.75%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104235722ab9edfc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104235722ab9edfc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.enterothera.com","stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.5157},{"period":"3month","weight":0.8739},{"period":"6month","weight":-0.6583},{"period":"1year","weight":-0.8306},{"period":"ytd","weight":-0.8528}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Entero Therapeutics, Inc.在美国特拉华州成立于2014年1月30日。该公司是一家临床阶段的生物制药公司，从事的是为胃肠功能紊乱患者的治疗，研究和开发非系统性生物制剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.137922},{"month":2,"riseRate":0.125,"avgChangeRate":-0.052571},{"month":3,"riseRate":0.25,"avgChangeRate":-0.106939},{"month":4,"riseRate":0.5,"avgChangeRate":-0.127653},{"month":5,"riseRate":0.25,"avgChangeRate":-0.115983},{"month":6,"riseRate":0.375,"avgChangeRate":-0.09714},{"month":7,"riseRate":0.25,"avgChangeRate":-0.267447},{"month":8,"riseRate":0.25,"avgChangeRate":-0.1523},{"month":9,"riseRate":0.125,"avgChangeRate":-0.229113},{"month":10,"riseRate":0.375,"avgChangeRate":0.034729},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.102505},{"month":12,"riseRate":0.666667,"avgChangeRate":0.055735}],"exchange":"NASDAQ","name":"Entero Therapeutics, Inc.","nameEN":"Entero Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Entero Therapeutics, Inc.(ENTO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Entero Therapeutics, Inc.(ENTO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Entero Therapeutics, Inc.,ENTO,Entero Therapeutics, Inc.股票,Entero Therapeutics, Inc.股票老虎,Entero Therapeutics, Inc.股票老虎国际,Entero Therapeutics, Inc.行情,Entero Therapeutics, Inc.股票行情,Entero Therapeutics, Inc.股价,Entero Therapeutics, Inc.股市,Entero Therapeutics, Inc.股票价格,Entero Therapeutics, Inc.股票交易,Entero Therapeutics, Inc.股票购买,Entero Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Entero Therapeutics, Inc.(ENTO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Entero Therapeutics, Inc.(ENTO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}